Wishbone Pet Products Inc. (Form: S-1, Received: 09/11/2012 17:04:53)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

Wishbone Pet Products Inc.

(Exact name of registrant as specified in its charter)

Nevada

0752

Pending

(State or jurisdiction of

Incorporation or organization)

Primary Standard Industrial
Classification Code Number

IRS Employer
Identification Number

38 ^th Street, New Sehaile,

Beirut, Lebanon
Telephone: 011-3-861-690
(Address and telephone number of principal executive offices)

Nevada Agency & Trust Company

50 West Liberty Street, Suite 880

Reno, Nevada 89501
Telephone: 775-322-0626

(Name, address and telephone number of agent for service)

Approximate date of proposed sale to the public:

as soon as practicable after the effective date of this Registration Statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box [X]

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company: in Rule 12b-2 of the Exchange Act (Check one):

	Large accelerated filer	[ ]	Accelerated filer	[ ]
	Non-accelerated filer	[ ]	Smaller reporting company	[X]
(Do not check if a smaller reporting company)

CALCULATION OF REGISTRATION FEE

TITLE OF EACH CLASS OF SECURITIES TO BE REGISTERED	AMOUNT TO BE REGISTERED	PROPOSED MAXIMUM OFFERING PRICE PER SHARE (1)	PROPOSED MAXIMUM AGGREGATE OFFERING PRICE (2)	AMOUNT OF REGISTRATION FEE (2)
Common Stock	1,500,000 shares	$0.01per share	$15,000	$1.72

(1)	Based on the last sales price on September 24, 2010
(2)	Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457 under the Securities Act.

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SECTION 8(a), MAY DETERMINE.

SUBJECT TO COMPLETION, Dated September 10, 2012

PROSPECTUS

WISHBONE PET PRODUCTS INC.

1,500,000 SHARES OF COMMON STOCK

The selling shareholders named in this prospectus are offering all of the shares of common stock offered through this prospectus for a period of up to two years from the effective date.

Our common stock is presently not traded on any market or securities exchange.

THE PURCHASE OF THE SECURITIES OFFERED THROUGH THIS PROSPECTUS INVOLVES A HIGH DEGREE OF RISK.

See section entitled “Risk Factors” on pages 5 - 8.

The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted .

The selling shareholders will sell our shares at $0.01 per share until our shares are quoted on the OTC Bulletin Board, and thereafter at prevailing market prices or privately negotiated prices. We determined this offering price based upon the price of the last sale of our common stock to investors. There is no assurance of when, if ever, our stock will be listed on an exchange.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

The Date Of This Prospectus Is: September 10, 2012

- 2 -

Table Of Contents

			PAGE
Summary			4
Risk Factors			5
	-	There is a substantial uncertainty as to whether we will continue as a going concern. If we discontinue operations, you will lose your investment.	5
	-	Because we have not commenced business operations, we face a high risk of business failure	5
	-	Because we have not yet patent protected our dog waste removal device, a competitor could copy our proposed design, which could cause our business to fail	5
	-	The pet products industry is extremely fragmented and competitive and we may not be able to compete successfully with existing competitors or new entrants in this market	6
	-	Because we operate in a foreign country, our business is subject to currency fluctuations and risk which could impact our revenue and results of operations. Also, since we hold our cash reserves in U.S. dollars, we may experience weakened purchasing power in Lebanese pounds and may not be able to afford the costs of our business plan	6
-	We are an “emerging growth company” and we intend to take advantage of reduced disclosure and governance requirements applicable to emerging growth companies, which could result in our common stock being less attractive to investors		6
-	Because management has limited experience in manufacturing and management, our business has a higher risk of failure		6
-	Because we rely on our sole employee, Rami Tabet, to conduct our operations, our business will likely fail if we lose his services		6
-	Because our president has other business interests, he may not be able or willing to devote a sufficient amount of time to our business operations, causing our business to fail		7
-	Upon the effectiveness of our registration statement, we will become a reporting issuer and will incur public disclosure costs. If we are unable to absorb these costs, our business plan will fail.		7
-	Because our business and ability to raise funds are adversely impacted by the current economic downturn, our ability to successfully implement our intended business plan may fail.		7
-	U.S. investors may experience difficulties in attempting to effect service of process and to enforce United States judgments against the company and its non-U.S. resident director and officer.		7
-	If a market for our common stock does not develop, shareholders may be unable to sell their shares		7
-	Because our president owns 57.14% of our outstanding common stock, he will make and control corporate decisions that may be disadvantageous to minority shareholders		7
-	A purchaser is purchasing penny stock, which limits his or her ability to sell the stock		8
Use of Proceeds			8
Determination of Offering Price			8
Dilution			8
Selling Shareholders			8
Plan of Distribution			10
Description of Securities			11
Interest of Named Experts and Counsel			12
Description of Business			12
Description of Property			15
Legal Proceedings			15
Market for Common Equity and Related Stockholder Matters			15
Financial Statements			16
Plan of Operation			18
Changes in and Disagreements with Accountants			19
Available Information			19
Directors, Executive Officers, Promoters and Control Persons			19
Executive Compensation			20
Security Ownership of Certain Beneficial Owners and Management			20
Certain Relationships and Related Transactions			21
Disclosure of Commission Position of Indemnification for Securities Act Liabilities			21

- 3 -

Summary

Prospective investors are urged to read this prospectus in its entirety.

We intend to commence business operations by developing, manufacturing, marketing, and selling dog waste removal devices. Our president, Rami Tabet, has developed a device concept that permits the user to enclose dog waste in a plastic bag this is contained inside of a sealed plastic case. The user can then disposed of the plastic bag without direct contact. To date, we have not manufactured or sold any dog waste removal devices. We will require significant additional funding in order to develop a product prototype so that it is suitable for mass production, to manufacture sufficient units of our product, and to market and sell our devices.

From our incorporation on July 30, 2009 to April 30, 2012, we have incurred an accumulated deficit of ($13,078). Further losses are anticipated in the development of our business. As a result, our auditor has expressed substantial doubt about our ability to continue as a going concern.

Our principal business office is located at 38 ^th Street, New Sehaile, Beirut, Lebanon, and our telephone number is (011) 961-3-861-690. Our fiscal year end is April 30. We were incorporated on July 30, 2009 under the laws of the state of Nevada.

The Offering :

Securities Being Offered		Up to 1,500,000 shares of common stock.

Offering Price		The selling shareholders will sell our shares at $0.01 per share until our shares are quoted on the OTC Bulletin Board, and thereafter at prevailing market prices or privately negotiated prices. We determined this offering price based upon the price of the last sale of our common stock to investors.

Terms of the Offering		The selling shareholders will determine when and how they will sell the common stock offered in this prospectus.

Termination of the Offering		The offering will conclude when all of the 1,500,000 shares of common stock have been sold, the shares no longer need to be registered to be sold, or we decide at any time to terminate the registration of the shares at our sole discretion. In any event, the offering shall be terminated no later than two years from the effective date of this registration statement.

Securities Issued And to be Issued		3,500,000 shares of our common stock are issued and outstanding as of the date of this prospectus. All of the common stock to be sold under this prospectus will be sold by existing shareholders.

Use of Proceeds		We will not receive any proceeds from the sale of the common stock by the selling shareholders.

Summary Financial Information

Balance Sheet

	April 30, 2012
	(audited)
Cash	$	12,539
Total Assets	$	12,539
Liabilities	$	8,617
Total Stockholders’ Equity	$	3,922

Statement of Operations

From Incorporation on
July 30, 2009 to April 30, 2012
(audited)

Revenue		$	0
Net Loss		$	(13,078	)

- 4 -

Risk Factors

An investment in our common stock involves a high degree of risk. You should carefully consider the risks described below and the other information in this prospectus before investing in our common stock. If any of the following risks occur, our business, operating results and financial condition could be seriously harmed. The trading price of our common stock could decline due to any of these risks, and you may lose all or part of your investment.

THERE IS SUBSTANTIAL UNCERTAINLY AS TO WHETHER WE WILL CONTINUE AS A GOING CONCERN. IF WE DISCONTINUE OPERATIONS, YOU WILL LOSE YOUR INVESTMENT.

We have incurred losses since our inception on July 30, 2009 resulting in an accumulated deficit of ($13,078) at April 30, 2012. Further losses are anticipated in the development of our business. As a result, there is substantial doubt about our ability to continue as a going concern. In fact, our auditors have issued a going concern opinion in connection with their audit of our financial statements for the fiscal years ended April 2012 and 2011. This means that our auditors believe there is substantial doubt that we can continue as an on-going business for the next twelve months.

Our ability to continue as a going concern is dependent upon our ability to generate profitable operations in the future and to obtain the necessary financing to expand our business operations, market our current product and develop new products.

Our ability to achieve and maintain profitability and positive cash flow is dependent upon:

●

our ability to design a dog waste removal device prototype so that it is appropriate for large scale manufacturing;

●

our success in identifying an appropriate manufacturer for our product;

●

our ability to successfully market and sell our product; and

●

our ability to raise enough capital to fund the above steps in our business plan.

Based upon current plans, we expect to incur operating losses in future periods because we will be incurring expenses and generating minimal revenues. We cannot guarantee that we will be successful in generating substantial revenues in the future. Failure to generate revenues will cause us to go out of business.

BECAUSE WE HAVE NOT COMMENCED BUSINESS OPERATIONS, WE FACE A HIGH RISK OF BUSINESS FAILURE.

We have not yet commenced manufacturing our intended product, a dog waste removal device that our president has designed. Accordingly, we have no way to evaluate the likelihood that our business will be successful. We were incorporated on July 30, 2009 and to date have been involved primarily in organizational activities. We have not earned any revenues as of the date of this prospectus. Potential investors should be aware of the difficulties normally encountered by development stage companies and the high rate of failure of such enterprises. The likelihood of success must be considered in light of the problems, expenses, difficulties, complications and delays encountered in product design, manufacturing, marketing, and the sale of new products.

There is no history upon which to base any assumption as to the likelihood that we will prove successful, and it is doubtful that we will generate any operating revenues or ever achieve profitable operations. If we are unsuccessful in addressing these risks, our business will most likely fail.

BECAUSE WE HAVE NOT YET PATENT PROTECTED OUR DOG WASTE REMOVAL DEVICE, A COMPETITOR COULD COPY OUR PROPOSED DESIGN, WHICH COULD CAUSE OUR BUSINESS TO FAIL.

Our potential competitive advantage lies in the potential unique design of our dog waste removal device prototype. Because we do not yet have a working prototype of our product, we have not applied for patent protection of our product. Accordingly, our business is subject to the risk that competitors could either copy or reverse engineer our design technology and manufacture and sell a competing product with similar features. If this occurs, our ability to sell our product could be jeopardized, which could cause our business to fail.

- 5 -

THE PET PRODUCTS INDUSTRY IS EXTREMELY FRAGMENTED AND COMPETITIVE AND WE MAY NOT BE ABLE TO COMPETE SUCCESSFULLY WITH EXISTING COMPETITORS OR NEW ENTRANTS IN THIS MARKET.

The pet products industry, including the pet waste removal sector, is extremely fragmented and competitive. The sector includes large entities that mass produce products for pets, as well as many boutique manufacturers that produce small batches of dog waste removal products and related accessories, such as plastic waste bags.

While the principal competitive factors in dog waste removal are product design and effectiveness, pricing and availability of the product and geographic coverage are also key. We will compete with many local, regional and national purveyors of pet products that offer multiple consumer items to pet and department stores and can therefore command better product placement. Most of our competitors have greater financial resources and may be able to withstand sales or price decreases better than we will. We also expect to continue to face competition from new market entrants. We may be unable to compete effectively with these existing or new competitors, which could have a material adverse effect on our financial condition and results of operations.

BECAUSE WE OPERATE IN A FOREIGN COUNTRY, OUR BUSINESS IS SUBJECT TO CURRENCY FLUCTUATIONS AND RISKS WHICH COULD IMPACT OUR REVENUE AND RESULTS OF OPERATIONS. ALSO, SINCE WE HOLD OUR CASH RESERVES IN US DOLLARS, WE MAY EXPERIENCE WEAKENED PURCHASING POWER IN LEBANESE POUNDS AND MAY NOT BE ABLE TO AFFORD THE COSTS OF OUR BUSINESS PLAN.

Although we hold our cash reserves in US dollars, we intend to operate our business partly in the Lebanese currency, the pound. Because some of our operations and expenses will be denominated in the Lebanese currency, due to foreign exchange rate fluctuations, the value of our reserves and the cash flow that we will receive will result in both translation gains and losses in terms of Lebanese pounds.

If there is a significant decline in the US dollar versus Lebanese pounds, our purchasing power in US dollars would significantly decline. As well, if there was a significant decline in the Lebanese pound relative to the US dollar, the amount of revenue and net profit that we may generate in Lebanon would be reduced in terms of US dollars, our financial statement reporting currency. We have not entered into derivative instruments to offset the impact of foreign exchange fluctuations.

WE ARE AN “EMERGING GROWTH COMPANY” AND WE INTEND TO TAKE ADVANTAGE OF REDUCED DISCLOSURE AND GOVERNANCE REQUIREMENTS APPLICABLE TO EMERGING GROWTH COMPANIES, WHICH COULD RESULT IN OUR COMMON STOCK BEING LESS ATTRACTIVE TO INVESTORS.

We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 and we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. We may take advantage of these reporting exemptions until we are no longer an emerging growth company, which in certain circumstances could be for up to five years.

BECAUSE MANAGEMENT HAS LIMITED EXPERIENCE IN MANUFACTURING AND MANAGEMENT, OUR BUSINESS HAS A HIGHER RISK OF FAILURE.

Rami Tabet, our sole employee, has no business experience in product design, manufacturing, marketing, or sales. In addition, Mr. Tabet’s management experience is limited to his involvement with our company. Consequently, management’s decisions and choices may not be well thought out and our operations, earnings and ultimate financial success may suffer irreparable harm as a result.

BECAUSE WE RELY ON OUR SOLE EMPLOYEE, RAMI TABET, TO CONDUCT OUR OPERATIONS, OUR BUSINESS WILL LIKELY FAIL IF WE LOSE HIS SERVICES.

We depend on the services of our senior management for the future success of our business. Our sole employee, Rami Tabet, is the only person who knows and understands the design concept of our dog waste removal product. Our success depends on the continued efforts of Mr. Tabet. We do not have a management agreement or any other similar arrangement with Mr. Tabet whereby he commits his services to us. The loss of the services of Mr. Tabet could have an adverse effect on our business, financial condition and results of operations.

- 6 -

B ECAUSE OUR PRESIDENT HAS OTHER BUSINESS INTERESTS, HE MAY NOT BE ABLE OR WILLING TO DEVOTE A SUFFICIENT AMOUNT OF TIME TO OUR BUSINESS OPERATIONS, CAUSING OUR BUSINESS TO FAIL.

Our president, Rami Tabet, spends approximately 25% of his business time providing his services to us. While Mr. Tabet presently possesses adequate time to attend to our interests, it is possible that the time demands on him from his other obligations could increase with the result that he would no longer be able to devote sufficient time to the management of our business.

UPON THE EFFECTIVENESS OF OUR REGISTRATION STATEMENT, WE WILL BECOME A REPORTING ISSUER AND WILL INCUR PUBLIC DISCLOSURE COSTS. IF WE ARE UNABLE TO ABSORB THESE COSTS, OUR BUSINESS PLAN WILL FAIL.

Upon the effectiveness of this registration statement, we will begin filing public disclosure documents with the Securities & Exchange Commission including financial reports on Form 10-K and Form 10-Q, as well as current reports on Form 8-K. In order to prepare these forms, we will incur legal, filing, accounting and audit costs that will result in an increase in general expenses. We estimate that the costs of this compliance will be approximately $10,000 per year. If we are unable to absorb these costs, we may be forced to cease operations.

BECAUSE OUR BUSINESS AND ABILITY TO RAISE FUNDS ARE ADVERSELY IMPACTED BY THE CURRENT ECONOMIC DOWNTURN, OUR ABILITY TO SUCCESSFULLY IMPLEMENT OUR INTENDED BUSINESS PLAN MAY FAIL.

Our intended business product, a dog waste removal device, is a consumer discretionary item. As such, demand for our product depends greatly on the disposable income of consumers. In the current global economic environment, it is likely that the demand for our product will be lower than it would be in an economic expansion. Due to this, our ability to sell significant units of our product may be impaired with the end result that our business plan fails. As well, economic conditions may make it difficult for us to raise the capital necessary to develop and expand our operations. If we are unable to raise funding because of this, our business will fail or our growth may be slower than anticipated.

U.S. INVESTORS MAY EXPERIENCE DIFFICULTIES IN ATTEMPTING TO EFFECT SERVICE OF PROCESS AND TO ENFORCE UNITED STATES JUDGMENTS AGAINST THE COMPANY AND ITS NON-U.S. RESIDENT DIRECTOR AND OFFICER.

While we are organized under the laws of State of Nevada, our sole director and officer is not a United States resident. Consequently, it will be difficult for investors to affect service of process on Mr. Tabet in the United States and to enforce in the United States judgments obtained in United States courts against Mr. Tabet or against us. Since all our assets may be located outside of U.S., it may be difficult or impossible for U.S. investors to collect a judgment against us. As well, any judgment obtained in the United States against us may not be enforceable in the United States.

IF A MARKET FOR OUR COMMON STOCK DOES NOT DEVELOP, SHAREHOLDERS MAY BE UNABLE TO SELL THEIR SHARES.

There is currently no market for our common stock and we can provide no assurance that a market will develop. We currently plan to apply for listing of our common stock on the over the counter bulletin board upon the effectiveness of the registration statement, of which this prospectus forms a part. However, we can provide investors with no assurance that our shares will be traded on the bulletin board or, if traded, that a public market will materialize. If no market is ever developed for our shares, it will be difficult for shareholders to sell their stock. In such a case, shareholders may find that they are unable to achieve benefits from their investment.

BECAUSE OUR PRESIDENT OWNS 57.14% OF OUR OUTSTANDING COMMON STOCK, HE WILL MAKE AND CONTROL CORPORATE DECISIONS THAT MAY BE DISADVANTAGEOUS TO MINORITY SHAREHOLDERS.

Our president, Rami Tabet, owns 57.14% of the outstanding shares of our common stock. Accordingly, he could potentially have significant influence in determining the outcome of all corporate transactions or other matters, including the election of directors, mergers, consolidations and the sale of all or substantially all of our assets, and also the power to prevent or cause a change in control. The interests of the individual may differ from the interests of the other stockholders and thus result in corporate decisions that are disadvantageous to other shareholders.

- 7 -

A PURCHASER IS PURCHASING PENNY STOCK WHICH LIMITS HIS OR HER ABILITY TO SELL OUR STOCK.

The shares offered by this prospectus constitute penny stock under the Exchange Act. The shares will remain penny stock for the foreseeable future. “Penny stock” rules impose additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors, that is, generally those with assets in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 together with a spouse. For transactions covered by these rules, the broker-dealer must make a special suitability determination for the purchase of such securities and have received the purchaser’s written consent to the transaction prior to the purchase.

Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the transaction, of a disclosure schedule prescribed by the Commission relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative and current quotations for the securities. Finally, monthly statements must be sent disclosing recent price information on the limited market in penny stocks. Consequently, the “penny stock” rules may restrict the ability of broker-dealers to sell our shares of common stock. The market price of our shares would likely suffer as a result.

Forward-Looking Statements

This prospectus contains forward-looking statements that involve risks and uncertainties. We use words such as anticipate, believe, plan, expect, future, intend and similar expressions to identify such forward-looking statements. You should not place too much reliance on these forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by us described in the “Risk Factors” section and elsewhere in this prospectus.

Use Of Proceeds

We will not receive any proceeds from the sale of the common stock offered through this prospectus by the selling shareholders.

Determination Of Offering Price

The selling shareholders will sell our shares at $0.01 per share until our shares are quoted on the OTC Bulletin Board, and thereafter at prevailing market prices or privately negotiated prices. We determined this offering price, based upon the price of the last sale of our common stock to investors. There is no assurance of when, if ever, our stock will be listed on an exchange.

Dilution

The common stock to be sold by the selling shareholders is common stock that is currently issued and outstanding. Accordingly, there will be no dilution to our other existing shareholders.

Selling Shareholders

The selling shareholders named in this prospectus are offering all of the 1,500,000 shares of common stock offered through this prospectus. These shares were acquired from us in a private placement that was exempt from registration under Regulation S of the Securities Act of 1933 and was completed on September 24, 2010.

The following table provides as of the date of this prospectus, information regarding the beneficial ownership of our common stock held by each of the selling shareholders, including:

	1.	the number of shares owned by each prior to this offering;
	2.	the total number of shares that are to be offered for each;
	3.	the total number of shares that will be owned by each upon completion of the offering; and
	4.	the percentage owned by each upon completion of the offering.

- 8 -

		Total Number
		Of Shares To	Total Shares	Percentage of
		Be Offered For	to Be Owned	Shares owned
Name Of	Shares Owned	Selling	Upon	Upon
Selling	Prior To This	Shareholders	Completion Of	Completion of
Stockholder	Offering	Account	This Offering	This Offering

Walid Rizk	50,000	50,000	Nil	Nil

Nirmin Awad	50,000	50,000	Nil	Nil

Tony Zahr	50,000	50,000	Nil	Nil

Wissam Hajdar	50,000	50,000	Nil	Nil

Yasmine Bazzi	50,000	50,000	Nil	Nil

Yehia Rahme	50,000	50,000	Nil	Nil

Hadi Youssef Moussa	50,000	50,000	Nil	Nil

Mohamad Hajj	50,000	50,000	Nil	Nil

Youssef Ali Mansour	50,000	50,000	Nil	Nil

Zakiah Riz	50,000	50,000	Nil	Nil

Zeina Riz	50,000	50,000	Nil	Nil

Mohamad Ali Sayegh	50,000	50,000	Nil	Nil

Najwa Sayegh	50,000	50,000	Nil	Nil

Taroub Sayegh	50,000	50,000	Nil	Nil

Jamal Sayegh	50,000	50,000	Nil	Nil

Raeef Sayegh	50,000	50,000	Nil	Nil

Tania Ahmad Assi	50,000	50,000	Nil	Nil

Issam Ahmad Assi	50,000	50,000	Nil	Nil

Ali Hussein Riz	50,000	50,000	Nil	Nil

Yasmeen Gharissa	50,000	50,000	Nil	Nil

Ali Zaateri	50,000	50,000	Nil	Nil

Wissam Gharissa	50,000	50,000	Nil	Nil

Ali Gharissa	50,000	50,000	Nil	Nil

Hussein Youssef Mansour	50,000	50,000	Nil	Nil

Hassan Sayegh	50,000	50,000	Nil	Nil

Moustapha Ghabriss	50,000	50,000	Nil	Nil

Rima Hamdan	50,000	50,000	Nil	Nil

Soha Hamdan	50,000	50,000	Nil	Nil

Bultu Wakjra	50,000	50,000	Nil	Nil

Tigist Biresa	50,000	50,000	Nil	Nil

- 9 -

The named party beneficially owns and has sole voting and investment power over all shares or rights to these shares. The numbers in this table assume that none of the selling shareholders sells shares of common stock not being offered in this prospectus or purchases additional shares of common stock, and assumes that all shares offered are sold. The percentages are based on 3,500,000 shares of common stock outstanding on the date of this prospectus.

None of the selling shareholders:

	(1)	has had a material relationship with us other than as a shareholder at any time within the past three years; or

	(2)	has ever been one of our officers or directors.

Plan Of Distribution

The selling shareholders may sell some or all of their common stock in one or more transactions, including block transactions. There are no arrangements, agreements or understandings with respect to the sale of these securities.

The shares may also be sold in compliance with the Securities and Exchange Commission’s Rule 144.

If applicable, the selling shareholders may distribute shares to one or more of their partners who are unaffiliated with us. Such partners may, in turn, distribute such shares as described above. If these shares being registered for resale are transferred from the named selling shareholders and the new shareholders wish to rely on the prospectus to resell these shares, then we must first file a prospectus supplement naming these individuals as selling shareholders and providing the information required concerning the identity of each selling shareholder and he or her relationship to us. There is no agreement or understanding between the selling shareholders and any partners with respect to the distribution of the shares being registered for resale pursuant to this registration statement.

We can provide no assurance that all or any of the common stock offered will be sold by the selling shareholders.

We are bearing all costs relating to the registration of the common stock. The selling shareholders, however, will pay any commissions or other fees payable to brokers or dealers in connection with any sale of the common stock.

The selling shareholders must comply with the requirements of the Securities Act and the Securities Exchange Act in the offer and sale of the common stock. In particular, during such times as the selling shareholders may be deemed to be engaged in a distribution of the common stock, and therefore be considered to be an underwriter, they must comply with applicable law and may, among other things:

	1.	Not engage in any stabilization activities in connection with our common stock;

	2.	Furnish each broker or dealer through which common stock may be offered, such copies of this prospectus, as amended from time to time, as may be required by such broker or dealer; and

	3.	Not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities other than as permitted under the Securities Exchange Act.

The Securities Exchange Commission has also adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges or quoted on the Nasdaq system, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system).

- 10 -

The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from those rules, deliver a standardized risk disclosure document prepared by the Commission, which:

	*	contains a description of the nature and level of risk in the market for penny stocks in both public offerings and secondary trading;
	*	contains a description of the broker’s or dealer’s duties to the customer and of the rights and remedies available to the customer with respect to a violation of such duties or other requirements
	*	contains a brief, clear, narrative description of a dealer market, including “bid” and “ask” prices for penny stocks and the significance of the spread between the bid and ask price;
	*	contains a toll-free telephone number for inquiries on disciplinary actions;
	*	defines significant terms in the disclosure document or in the conduct of trading penny stocks; and
	*	contains such other information and is in such form (including language, type, size, and format) as the Commission shall require by rule or regulation;

The broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with:

	*	bid and offer quotations for the penny stock;
	*	the compensation of the broker-dealer and its salesperson in the transaction;
	*	the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for such stock; and
	*	monthly account statements showing the market value of each penny stock held in the customer’s account.

In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from those rules; the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written acknowledgment of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitability statement. These disclosure requirements will have the effect of reducing the trading activity in the secondary market for our stock because it will be subject to these penny stock rules. Therefore, stockholders may have difficulty selling those securities.

Description Of Securities

General

Our authorized capital stock consists of 200,000,000 shares of common stock at a par value of $0.001 per share.

Common Stock

As of September 10, 2012, there were 3,500,000 shares of our common stock issued and outstanding that are held by 31 stockholders of record.

Holders of our common stock are entitled to one vote for each share on all matters submitted to a stockholder vote. Holders of common stock do not have cumulative voting rights. Therefore, holders of a majority of the shares of common stock voting for the election of directors can elect all of the directors. Holders of our common stock representing a majority of the voting power of our capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute a quorum at any meeting of our stockholders. A vote by the holders of a majority of our outstanding shares is required to effectuate certain fundamental corporate changes such as liquidation, merger or an amendment to our articles of incorporation.

Holders of common stock are entitled to share in all dividends that the board of directors, in its discretion, declares from legally available funds. In the event of a liquidation, dissolution or winding up, each outstanding share entitles its holder to participate pro rata in all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over the common stock. Holders of our common stock have no pre-emptive rights, no conversion rights and there are no redemption provisions applicable to our common stock.

Preferred Stock

We do not have an authorized class of preferred stock.

Dividend Policy

We have never declared or paid any cash dividends on our common stock. We currently intend to retain future earnings, if any, to finance the expansion of our business. As a result, we do not anticipate paying any cash dividends in the foreseeable future.

- 11 -

Share Purchase Warrants

We have not issued and do not have outstanding any warrants to purchase shares of our common stock.

Options

We have not issued and do not have outstanding any options to purchase shares of our common stock.

Convertible Securities

We have not issued and do not have outstanding any securities convertible into shares of our common stock or any rights convertible or exchangeable into shares of our common stock.

Interests Of Named Experts And Counsel

No expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of the common stock was employed on a contingency basis, or had, or is to receive, in connection with the offering, an interest, direct or indirect, in the registrant or any of its parents or subsidiaries. Nor was any such person connected with the registrant or any of its parents or subsidiaries as a promoter, managing or principal underwriter, voting trustee, director, officer, or employee.

●, has provided an opinion on the validity of our common stock.

The financial statements included in this prospectus and the registration statement have been audited by George Stewart, Certified Public Accountant, to the extent and for the periods set forth in their report appearing elsewhere in this document and in the registration statement filed with the SEC, and are included in reliance upon such report given upon the authority of said firm as experts in auditing and accounting.

Description Of Business

Product Overview

We intend to commence business operations by developing, manufacturing, marketing, and selling dog waste removal devices. While we were incorporated on July 30, 2009, we have only recently taken steps to proceed with our intended business plan. Our president, Rami Tabet, has designed a device concept that permits the user to enclose dog waste in a plastic bag this is contained inside of a sealed plastic case. The user can then disposed of the plastic bag without direct contact. To date, we have not manufactured or sold any dog waste removal devices. We will require significant additional funding in order to design a product prototype so that it is suitable for mass production, to manufacture sufficient units of our product, and to market and sell our devices.

Market for the Product

Dog owners are under community pressure, and often legal requirements, to remove solid waste that their pets produce in public places and on the private property of third parties during walks. Failure of an owner to retrieve dog waste may be considered a public health and can result in an owner being subject to significant fines. While many owners use various forms of plastic bags to retrieve dog waste from the ground, this places the owner in close contact with the waste, which is considered unpleasant. Our business plan is based on the premise that dog owner’s will be prepared to purchase a dog waste retrieval product that allows them to collect and dispose of dog waste at a distance.

Product Design

Our proposed product would allow dog owners to collect dog waste with a simple one-handed operation from a distance of approximately three feet. The apparatus would consist of a plastic handle which the owner holds, a three foot straight piece of plastic that joins the handle to a plastic case, and the sealed plastic case that would collect the dog waste. A lever mechanism at the base of the handle would allow the owner to open and close the sealed plastic case.

Prior to taking a dog for a walk, the owner would insert a plastic, elastic-edge, liner bag in the sealed plastic case. To use the device, the owner would position the unit, with the plastic case open, over the dog waste to be collected. He or she would then press the handle lever in order to close the plastic case. The plastic case mechanism would then seal the waste inside of the liner bag, which would automatically be sealed upon closure. When the owner wishes to dispose of the liner bag full of waste in a garbage receptacle, he or she would simply move the lever and the waste-filled bag would drop.

- 12 -

We would also develop, manufacture, and sell replacement liner bags that are specially designed to fit the dog waste removal device. We intend to offer standard bags composed of polyethylene film with an elastic edge, as well as biodegradable bags made of water soluble film.

We anticipate that we will retain consultants and third parties to design a prototype for our product, as well as manufacture and package our product. We would be primarily responsible for marketing, distributing, and selling our product, though we may decide to outsource aspects of these tasks as well.

Existing Competitive Products

While various companies offer dog waste retrieval products, we are not aware of any that have all of the features of our proposed product. Current dog waste removal products fall into one of the following categories:

1. Mechanisms with bags

Products in this group use a mechanism in conjunction with a bag to collect, carry, and dispose of dog waste. Such products require the user to seal the bag by hand and many require the user to manually dispose of the bag. In practice these products are difficult to manipulate effectively and the manner of operation results in incomplete retrieval of the waste or unintended smearing of waste on the device. As well, such devices still require the dog owner to be in close proximity of the dog waste.

2. Mechanisms without bags

Products in this group use some type of mechanism to collect, carry, and dispose of dog waste. While these products suffer the same disadvantages as the products in the first group, the primary disadvantage of these products is that they tend to gather dog waste residue and therefore require periodic cleaning. This group also includes rakes and shovels.

3. Modified bags

Products in this group include paper or plastic bags that have features added, such as cardboard or stiff plastic, to keep the users hand from directly touching the dog waste and make it less distasteful to pick up dog waste. These products are often bulky and awkward, making transport and handling quite difficult. Moreover, these products can present difficult cleaning problems and require the dog owner to be in close proximity of the dog waste. Accordingly, such products can be considered objectionable from an aesthetic and functional standpoint.

4. Bags

This group consists of ordinary plastic bags, which are slightly modified or not modified at all. Modified bags include scented bags, biodegradable bags, and bags with built-in ties. While use of a plastic bag is the most commonly employed means for cleaning up dog waste and is the least expensive, it is also one of the most objectionable. The user must come into direct tactile and olfactory contact with the dog waste. In addition, the bag requires careful handling until a suitable waste receptacle is located.

We intend to design a dog waste retrieval device that overcome the disadvantages of these existing products in order to achieve a competitive advantage. Our business strategy is based on the view that dog owners will be willing to pay for a dog waste removal product that allows them to avoid close contact with the waste.

Sales and Marketing Strategy

Assuming that we are successful in designing a dog waste removal device prototype and manufacturing such a product for distribution and sale, our proposed marketing strategy is to simply and succinctly explain our product to our target market, dog owners. We expect that our marketing strategy will be most successful if we are able to visually demonstrate the use of our product and also verbally explain its advantages. To this end, we would likely engage in retail product demonstrations at retail locations, develop commercials for presentation on cable television, and develop a website that includes video footage depicting the use of our dog waste removal product. As well, we intend to package our product in a fashion that allows potential consumers to try the product by moving its lever in order to open and close the seal plastic case that is intended to collect dog waste.

- 13 -

We intend to sell our dog waste removal product and liner bags through distribution arrangements with pet stores of various sizes, as well as general retailers, which include supermarkets, discount stores, and large chain stores. We hope to enter into agreements with both regional and national pet product distributors, though there is no guarantee that we will be successful in reaching such arrangements. We will also sell our products on a company website, though we will commit to any distributors and retailers that we will not sell our products through our website for less than the manufacturer’s suggested retail price, which we expect to be approximately $30 for the device and approximately $7 for a box of 50 replacement bags.

Government Regulation

While most pet product regulation relates to food and treats, we will have to comply with laws relating to product labeling, the truth and accuracy of product claims, and general safety requirements for consumer products.

We will be required to comply with the National Institute of Standards and Technology’s Handbook of Uniform Packaging and Labeling Regulations and the Fair Packaging and Labeling Act that enumerates measurement and labeling requirements for products. This will be particularly applicable to our liner bag packages, which must accurately state the number of bags in each box.

We must also ensure that we are able to substantiate the truth of any claims that we make regarding the performance of our product in order to comply with the requirements for consumer products that the Federal Trade Commission establishes. We must also demonstrate that our product is safe for use in accordance with the requirements of the Consumer Products Safety Commission.

We do not anticipate that our cost of compliance with applicable government regulations will be material.

Subsidiaries

We do not have any subsidiaries.

Patents and Trademarks

We do not own, either legally or beneficially, any patents or trademarks. Once we have completed an operating prototype of our dog waste removal device, we anticipate that we will seek patent protection for its design. As well, once we have selected a name for our device, we will attempt to register a trademark in order to protect the name.

Governmental and Industry Regulations

We will be subject to federal and state laws and regulations that relate directly or indirectly to our operations including federal securities laws. We will also be subject to common business and tax rules and regulations pertaining to the operation of our business.

Research and Development Activities and Costs

We have not spent any funds on research and development activities to date.

Compliance with Environmental Laws

Our current operations are not subject to any environmental laws.

Facilities

We do not own or rent facilities of any kind. We plan to conduct our operations from the office of our president until we are in a position to commence and expand operations.

Employees

We have commenced only limited operations, and therefore currently have no employees other than our sole officer and director.

Reports to Stockholders

We are not currently a reporting company, but upon effectiveness of the registration statement, of which this prospectus forms a part, we will be required to file reports with the SEC pursuant to the Securities Exchange Act of 1934, as amended. These reports include annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. You may obtain copies of these reports from the SEC’s Public Reference Room at 100 F Street, NE., Washington, DC 20549, on official business days during the hours of 10 a.m. to 3 p.m. or on the SEC’s website, at www.sec.gov. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.

- 14 -

Description Of Property

We do not own any real property interest. Our offices are located at 38 ^th Street, New Sehaile, Beirut, Lebanon.

Legal Proceedings

We are not currently a party to any legal proceedings. Our address for service of process in Nevada is 50 West Liberty Street, Suite 880, Reno, Nevada, 89501.

Market For Common Equity And Related Stockholder Matters

No Public Market for Common Stock

There is presently no public market for our common stock. We anticipate applying for trading of our common stock on the over the counter bulletin board upon the effectiveness of the registration statement of which this prospectus forms a part. However, we can provide no assurance that our shares will be traded on the bulletin board or, if traded, that a public market will materialize.

Stockholders of Our Common Shares

As of the date of this registration statement, we have 31 registered shareholders.

Rule 144 Shares

Our shares of common stock are not currently available for resale to the public in accordance with the volume and trading limitations of Rule 144 of the Act because we are a shell company. Our shareholders cannot rely on Rule 144 for the resale of our common stock

until the following have occurred:

we have ceased to be a shell company;

we are subject to the reporting requirements of the Exchange Act, which we are;

we have filed all Exchange Act reports required for the past 12 months, which we have; and

a minimum of one year has elapsed since we filed current Form 10 information on Form 8-K changing our status from a shell company to a non-shell company.

When Rule 144 is available, our affiliate stockholders shall be entitled to sell within any three month period a number of shares that does not exceed 1% of the number of shares of the company’s common stock then outstanding which, in our case, will equal 35,000, shares as of the date of this prospectus based on our current issued and outstanding share capital of 3,500,000 shares of common stock.

Sales under Rule 144 are also subject to manner of sale provisions and notice requirements and to the availability of current public information about the company.

Stock Option Grants

To date, we have not granted any stock options.

Registration Rights

We have not granted registration rights to the selling shareholders or to any other persons.

- 15 -

Dividends

There are no restrictions in our articles of incorporation or bylaws that prevent us from declaring dividends. The Nevada Revised Statutes, however, do prohibit us from declaring dividends where, after giving effect to the distribution of the dividend:

	1.	we would not be able to pay our debts as they become due in the usual course of business; or
	2.	our total assets would be less than the sum of our total liabilities plus the amount that would be needed to satisfy the rights of shareholders who have preferential rights superior to those receiving the distribution.

We have not declared any dividends, and we do not plan to declare any dividends in the foreseeable future.

Financial Statements

Index to Financial Statements :

1.	Report of Independent Registered Public Accounting Firm;

2.	Audited financial statements for the period from July 30, 2009 (inception) to April 30, 2010 and for the fiscal years ended April 30, 2012 and 2011, including:

	a.	Balance Sheets;
	b.	Statements of Operations;
	c.	Statements of Cash Flows;
	d.	Statements of Stockholders’ Equity (Deficit); and
	e.	Notes to Financial Statements

- 16 -

GEORGE STEWART, CPA

316 17TH AVENUE SOUTH

SEATTLE, WASHINGTON 98144

(206) 328-8554 FAX (206) 328-0383

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors

Wishbone Pet Products Inc.

I have audited the accompanying balance sheets of Wishbone Pet Products Inc. (A Development Stage Company) as of April 30, 2012 2011 and 2010, and the related statements of operations, stockholders’ equity and cash flows for the years ended January 31, 2012, 2011 and 2010 and for the period from July 30, 2009 (inception), to April 30, 2012. These financial statements are the responsibility of the Company’s management. My responsibility is to express an opinion on these financial statements based on my audit.

I conducted my audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that I plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. I believe that my audit provides a reasonable basis for my opinion.

In my opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Wishbone Pet Products Inc., (A Development Stage Company) as of January 31, 2012, 2011 and 2010, and the results of its operations and cash flows for the years ended January 31, 2012, 2011 and 2010 and the period from July 30, 2009 (inception), to April 30, 2012 in conformity with generally accepted accounting principles in the United States of America.

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note # 2 to the financial statements, the Company has had no operations and has no established source of revenue. This raises substantial doubt about its ability to continue as a going concern. Management’s plan in regard to these matters is also described in Note # 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/S/ George Stewart

Seattle, Washington
August 1, 2012

- 17 -

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

BALANCE SHEET

April 30, 2010

ASSETS
Cash	$	1,969

TOTAL ASSETS	$	1,969

LIABILITIES & SHAREHOLDER’S EQUITY

LIABILITIES
Accounts payable	$	3,851


SHAREHOLDER’S EQUITY
Capital stock authorized: 200,000,000 common shares with a par value $0.001
Issued and outstanding: 2,000,000 common shares

Capital stock	$	2,000
Additional paid-in capital		-
Deficit accumulated during the developmental stage		(3,882	)
		(1,882	)

TOTAL LIABILITIES & SHAREHOLDER’S EQUITY	$	1,969

F- 1

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

INCOME STATEMENT

For the year ended April 30, 2010

	For the period
	ended
	April 30, 2010
OPERATING EXPENSES

Professional fees	$	3,400
General & administrative expenses		483

TOTAL EXPENSES		3,883

OPERATING LOSS	$	(3,883	)


OTHER INCOME

Interest income		1


NET INCOME/(LOSS)	$	(3,882	)


Net loss per share, basic and diluted	$	(0.005	)

Weighted average common shares outstanding, basic and diluted		839,416

F- 2

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

STATEMENT OF CHANGES IN STOCKHOLDER’S EQUITY

For the period July 30, 2009 to the year ended April 30, 2010

	Common Stock
	200,000,000 shares authorized				Additional					Total
	Shares		Par Value		Paid in		Accumulated			Shareholder’s
	Issued		$.001 per share		Capital		Deficit			Equity

Shares issued at $0.001		2,000,000	$	2,000	$	-	$	-		$	2,000
Net income/loss								(3,882	)		(3,882	)
Balance, April 30, 2010		2,000,000	$	2,000	$	-	$	(3,882	)	$	(1,882	)

F- 3

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

STATEMENT OF CASH FLOWS

For the year ended April 30, 2010

	For the year
	Ended
	April 30, 2010

Net income/(loss)	$	(3,882	)
Adjustments to reconcile net income to net cash:

Changes in current assets and liabilities:
Accounts payable		4,399

Net cash used in operating activities	$	517

Cash Flows from Investing Activities
	$	-

Net cash used in investing activities	$	-


Cash Flows from Financing Activities
Proceeds from the issuance of common stock	$	2,000

Net cash provided by financing activities	$	2,000

Net cash flows from operations	$	2,517

Cash and cash equivalents, beginning of period	$	-

Cash and cash equivalents, end of period	$	2,517

F- 4

WISHBONE PET PRODUCTS INC.

(A Development Stage Company)

Notes to the Financial Statement

April 30, 2010

Note 1 Nature and Continuance of Operations

Wishbone Pet Products Inc. was incorporated in the State of Nevada on July 30, 2009. The Company has been in the development stage since its formation and has not realized any revenues from its planned operations. The Company is primarily engaged in the business of developing, manufacturing, marketing and selling dog waste removal devices.

The Company has chosen an April 30 fiscal year end.

Note 2 Basis of Presentation – Going Concern Uncertainties

These financial statements have been prepared in conformity with generally accepted accounting principles in the United States, which contemplate continuation of the Company as a going concern. The Company is at its early stages of development and has limited operations, and has sustained operating losses resulting in a deficit.

The Company has accumulated a deficit of $3,882 since inception, has yet to achieve profitable operations and further losses are anticipated in the development of its business. The Company’s ability to continue as a going concern is in substantial doubt and is dependent upon obtaining financing and/or achieving a sustainable profitable level of operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company may seek additional equity as necessary and it expects to raise funds through private or public equity investment or loans from directors of the Company in order to support existing operations. There is no assurance that such additional funds will be available for the Company on acceptable terms, if at all.

Note 3 Summary of Principal Accounting Policies

Basis of presentation

The accompanying financial statements are stated in US dollars and have been prepared in accordance with generally accepted accounting principles in the United States of America.

Cash and cash equivalents

The Company considers all short-term highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less to be cash equivalents.

F- 5

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes its best estimate of the ultimate outcome for these items based on historical trends and other information available when the financial statements are prepared. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates.

Income Taxes

The Company follows the guideline under ASC Topic 740 “Income Taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Since the Company is in the developmental stage and has losses, no deferred tax asset or income taxes have been recorded in the financial statements.

Financial instruments

The Company’s financial instruments consist of cash, accounts payable and accrued liabilities and their carrying values approximate fair value because of their short-term nature. Management is of the opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.

Development Stage Company

The Company has not earned any revenue from limited principal operations. Accordingly, the Company’s activities have been accounted for as those of a “Development Stage Entity” as set forth in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 915. Among the disclosures required by ASC Topic 915 are that the Company’s financial statements be identified as those of a development stage company, and that the statements of earnings, retained earnings and stockholders’ equity and cash flows disclose activity since the date of the Company’s inception. All losses accumulated since inception has been considered as part of the Company’s development stage activities.

F- 6

Fair value measurements

The Company follows the guidelines in ASC Topic 820 “Fair Value Measurements and Disclosures”. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities

Level 3—inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models.

ASC Topic 820, in and of itself, does not require any fair value measurements. As at April 30, 2010, the Company did not have assets or liabilities subject to fair value measurement.

Loss per share

The Company reports basic loss per share in accordance with ASC Topic 260 “Earnings Per Share” (“EPS”). Basic loss per share is based on the weighted average number of common shares outstanding and diluted EPS is based on the weighted average number of common shares outstanding and dilutive common stock equivalents. Basic EPS is computed by dividing net loss (numerator) applicable to common stockholders by the weighted average number of common shares outstanding (denominator) for the period. There are no potentially dilutive securities outstanding and therefore, diluted earnings per share on not presented. All per share and per share information are adjusted retroactively to reflect stock splits and changes in par value.

Concentration of credit risk

The Company places its cash and cash equivalents with a high credit quality financial institution. The Company maintains United States Dollars at a bank in the Switzerland that are not insured. The Company minimizes its credit risks associated with cash by periodically evaluating the credit quality of its primary financial institution.

F- 7

Recently issued accounting pronouncements

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. Management does not believe that any pronouncement not yet effective but recently issued by the FASB (including its Emerging Issues Task Force), the AICPA or the SEC would, if adopted, have a material effect on the accompanying financial statements

Note 4 Common stock

On January 5, 2010, the Company authorized issuance of 2,000,000 restricted common stock, at a unit price of $0.001 per share, as part of a Section 4(2) subscription to the directors of the Company. Total proceeds were $2,000.

F- 8

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

BALANCE SHEETS

	April 30, 2011			April 30, 2010
ASSETS
Cash	$	13,039		$	1,969

TOTAL ASSETS	$	13,039		$	1,969

LIABILITIES & SHAREHOLDER’S EQUITY

LIABILITIES
Accounts payable	$	3,917		$	3,851


SHAREHOLDER’S EQUITY
Capital stock authorized: 200,000,000 common shares with a par value $0.001
Issued and outstanding: 3,500,000 common shares
Capital stock	$	3,500		$	2,000
Additional paid-in capital		13,500			-
Deficit accumulated during the developmental stage		(7,878	)		(3,882	)
		9,122			(1,882	)

TOTAL LIABILITIES & SHAREHOLDER’S EQUITY	$	13,039		$	1,969

F- 9

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

INCOME STATEMENTS

For the years ended April 30, 2011 and 2010, and

For the period from July 30, 2009 (inception) to April 30, 2011

							From the period
	For the year ended						July 30, 2009
	April 30,						(inception) to
	2011			2010			April 30, 2011
OPERATING EXPENSES

Professional fees	$	66		$	3,400		$	3,466
General & administrative expenses		3,934			483			4,417

TOTAL EXPENSES		4,000			3,883			7,883

OPERATING LOSS	$	(4,000	)	$	(3,883	)	$	(7,883	)

OTHER INCOME

Interest income		4			1			5

NET INCOME/(LOSS)	$	(3,996	)	$	(3,882	)	$	(7,878	)


Net loss per share, basic and diluted	$	(0.001	)	$	(0.005	)

Weighted average common shares outstanding basic and diluted		3,145,479			839,416

F- 10

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

STATEMENT OF CHANGES IN STOCKHOLDER’S EQUITY

For the period July 30, 2009 to April 30, 2011

	Common Stock
	200,000,000 shares authorized				Additional					Total
	Shares		Par Value		Paid in		Accumulated			Shareholder’s
	Issued		$.001 per share		Capital		Deficit			Equity

Shares issued at $0.001		2,000,000	$	2,000	$	-	$	-		$	2,000
Net income/loss								(3,882	)		(3,882	)
Balance, April 30, 2010		2,000,000	$	2,000	$	-	$	(3,882	)	$	(1,882	)

Shares issued at $0.01		1,500,000		1,500		13,500					15,000
Net income/loss								(3,996	)		(3,996	)
Balance, April 30, 2011		3,500,000	$	3,500	$	13,500	$	(7,878	)	$	9,122

F- 11

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

STATEMENT OF CASH FLOWS

For the years ended April 30, 2011 and 2010, and

For the period from July 30, 2009 (inception) to April 30, 2011

							From the period
	For the year ended						July 30, 2009
	April 30,						(inception) to
	2011			2010			April 30, 2011

Net income/(loss)	$	(3,996	)	$	(3,882	)	$	(7,878	)
Adjustments to reconcile net income to net cash:

Changes in current assets and liabilities:
Accounts payable		66			3,851			3,917

Net cash used in operating activities	$	(3,930	)	$	(31	)	$	(3,961	)

Cash Flows from Investing Activities
	$	-		$	-		$	-

Net cash used in investing activities	$	-		$	-		$	-

Cash Flows from Financing Activities
Proceeds from the issuance of common stock	$	15,000		$	2,000		$	17,000

Net cash provided by financing activities	$	15,000		$	2,000		$	17,000

Net cash flows from operations	$	11,070		$	1,969		$	13,039

Cash and cash equivalents, beginning of period	$	1,969		$	-		$	-

Cash and cash equivalents, end of period	$	13,039		$	1,969		$	13,039

F- 12

WISHBONE PET PRODUCTS INC.

(A Development Stage Company)

Notes to the Financial Statement

April 30, 2011

Note 1 Nature and Continuance of Operations

The Company has chosen an April 30 fiscal year end.

Note 2 Basis of Presentation – Going Concern Uncertainties

The Company has accumulated a deficit of $7,878 since inception, has yet to achieve profitable operations and further losses are anticipated in the development of its business. The Company’s ability to continue as a going concern is in substantial doubt and is dependent upon obtaining financing and/or achieving a sustainable profitable level of operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company may seek additional equity as necessary and it expects to raise funds through private or public equity investment or loans from directors of the Company in order to support existing operations. There is no assurance that such additional funds will be available for the Company on acceptable terms, if at all.

Note 3 Summary of Principal Accounting Policies

Basis of presentation

The accompanying financial statements are stated in US dollars and have been prepared in accordance with generally accepted accounting principles in the United States of America.

Cash and cash equivalents

The Company considers all short-term highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less to be cash equivalents.

F- 13

Use of estimates

Income Taxes

Financial instruments

Development Stage Company

F- 14

Fair value measurements

Level 1 — Quoted prices in active markets for identical assets or liabilities.

ASC Topic 820, in and of itself, does not require any fair value measurements. As at April 30, 2011, the Company did not have assets or liabilities subject to fair value measurement.

Loss per share

Concentration of credit risk

F- 15

Recently issued accounting pronouncements

Note 4 Common stock

During the year ended April 30, 2011, the Company received an aggregate $15,000 for the issuance of 1,500,000 restricted common stock at a price of $0.01 per share.

F- 16

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

BALANCE SHEETS

	April 30, 2012			April 30, 2011
ASSETS
Cash	$	12,539		$	13,039

TOTAL ASSETS	$	12,539		$	13,039

LIABILITIES & SHAREHOLDER’S EQUITY

LIABILITIES
Accounts payable	$	8,617		$	3,917

SHAREHOLDER’S EQUITY
Capital stock authorized: 200,000,000 common shares with a par value $0.001
Issued and outstanding: 3,500,000 common shares
Capital stock	$	3,500		$	3,500
Additional paid-in capital		13,500			13,500
Deficit accumulated during the developmental stage		(13,078	)		(7,878	)
		3,922			9,122

TOTAL LIABILITIES & SHAREHOLDER’S EQUITY	$	12,539		$	13,039

F- 17

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

INCOME STATEMENTS

For the years ended April 30, 2012 and 2011, and

For the period from July 30, 2009 (inception) to April 30, 2012

							From the period
	For the year ended						July 30, 2009
	April 30,						(inception) to
	2012			2011			April 30, 2012
OPERATING EXPENSES

Professional fees	$	4,700		$	66		$	8,166
General & administrative expenses		501			3,934			4,917

TOTAL EXPENSES		5,201			4,000			13,083

OPERATING LOSS	$	(5,201	)	$	(4,000	)	$	(13,083	)

OTHER INCOME

Interest income		1			4			5

NET INCOME/(LOSS)	$	(5,200	)	$	(3,996	)	$	(13,078	)

Net loss per share, basic and diluted	$	(0.001	)	$	(0.001	)

Weighted average common shares outstanding basic and diluted		3,500,000			3,145,479

F- 18

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

STATEMENT OF CHANGES IN STOCKHOLDER’S EQUITY

For the period July 30, 2009 to April 30, 2012

	Common Stock
	200,000,000 shares authorized				Additional					Total
	Shares		Par Value		Paid in		Accumulated			Shareholder’s
	Issued		$.001 per share		Capital		Deficit			Equity

Shares issued at $0.001		2,000,000	$	2,000	$	-	$	-		$	2,000
Net income/loss								(3,882	)		(3,882	)
Balance, April 30, 2010		2,000,000	$	2,000	$	-	$	(3,882	)	$	(1,882	)

Shares issued at $0.01		1,500,000		1,500		13,500					15,000
Net income/loss								(3,996	)		(3,996	)
Balance, April 30, 2011		3,500,000	$	3,500	$	13,500	$	(7,878	)	$	9,122

Net income/loss								(5,200	)		(5,200	)
Balance, April 30, 2012		3,500,000	$	3,500	$	13,500	$	(13,078	)	$	3,922

F- 19

WISHBONE PET PRODUCTS INC.

(A Developmental Stage Company)

STATEMENT OF CASH FLOWS

For the years ended April 30, 2012 and 2011, and

For the period from July 30, 2009 (inception) to April 30, 2012

							From the period
	For the year ended						July 30, 2009
	April 30,						(inception) to
	2012			2011			April 30, 2012

Net income/(loss)	$	(5,200	)	$	(3,996	)	$	(13,078	)
Adjustments to reconcile net income to net cash:

Changes in current assets and liabilities:
Accounts payable		4,700			66			8,617

Net cash used in operating activities	$	(500	)	$	(3,930	)	$	(4,461	)

Cash Flows from Investing Activities
	$	-		$	-		$	-

Net cash used in investing activities	$	-		$	-		$	-

Cash Flows from Financing Activities
Proceeds from the issuance of common stock	$	-		$	15,000		$	17,000

Net cash provided by financing activities	$	-		$	15,000		$	17,000

Net cash flows from operations	$	(500	)	$	11,070		$	12,539

Cash and cash equivalents, beginning of period	$	13,039		$	1,969		$	-

Cash and cash equivalents, end of period	$	12,539		$	13,039		$	12,539

F- 20

WISHBONE PET PRODUCTS INC.

(A Development Stage Company)

Notes to the Financial Statement

April 30, 2012

Note 1 Nature and Continuance of Operations

The Company has chosen an April 30 fiscal year end.

Note 2 Basis of Presentation – Going Concern Uncertainties

The Company has accumulated a deficit of $13,078 since inception, has yet to achieve profitable operations and further losses are anticipated in the development of its business. The Company’s ability to continue as a going concern is in substantial doubt and is dependent upon obtaining financing and/or achieving a sustainable profitable level of operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company may seek additional equity as necessary and it expects to raise funds through private or public equity investment or loans from directors of the Company in order to support existing operations. There is no assurance that such additional funds will be available for the Company on acceptable terms, if at all.

Note 3 Summary of Principal Accounting Policies

Basis of presentation

The accompanying financial statements are stated in US dollars and have been prepared in accordance with generally accepted accounting principles in the United States of America.

Cash and cash equivalents

The Company considers all short-term highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less to be cash equivalents.

F- 21

Use of estimates

Income Taxes

Financial instruments

Development Stage Company

F- 22

Fair value measurements

Level 1 — Quoted prices in active markets for identical assets or liabilities.

ASC Topic 820, in and of itself, does not require any fair value measurements. As at April 30, 2012, the Company did not have assets or liabilities subject to fair value measurement.

Loss per share

Concentration of credit risk

F- 23

Recently issued accounting pronouncements

Note 4 Common stock

During the year ended April 30, 2011, the Company received an aggregate $15,000 for the issuance of 1,500,000 restricted common stock at a price of $0.01 per share.

F- 24

Plan Of Operation

Our plan of operation for the twelve month period following the date of this prospectus is to create a prototype of our dog waste removal device based on the initial design specifications that our president has delineated. We intend to accomplish these goals by either retaining a product sourcing consultant or working directly with a prototype development engineering firm. To date, we have identified potential consultants and prototype development firms, but we have not entered into any contractual relationships with any of them.

The specific business milestones that we hope to achieve are as follows:

●

from September 2012 to December 2012, our president, Rami Tabet, intends to prepare formal, graphic depictions of the dog waste removal product, as well as the product specifications that he envisions, that will form the basis of the prototype design;

●

from January 2013 to February 2013, Mr. Tabet will contact various product sourcing consultants and prototype development engineering firms in order to determine which companies can design a prototype of the dog waste retrieval device, the anticipated time-frame for development, and the expected cost;

●

By April 2013, we expect to execute a prototype development agreement with a third party and then provide all necessary information for that company to proceed with the prototype creation;

●

In conjunction with the prototype development company, we expect to create, revise as necessary, and finalize a prototype of the dog waste removal device for potential mass manufacture by December 2013. This will include ongoing collaboration between us and the prototype development company, prototype testing, any redesign requirements.

We expect to incur the following costs in the next 12 months in connection with our prototype design:

Consulting and engineering costs:	$	25,000
General and administrative costs:	$	10,000

Total:	$	35,000

It is possible that actual consulting and engineering costs will exceed our estimates. As well, our current cash on hand is not sufficient to meet our anticipated obligations for the next twelve-month period. We intend to raise additional funding either through the sale of our common stock to investors or through loans from our director. However, we do not have any commitments in this regard. If we are unable to raise the required financing, we will be delayed in conducting our business plan.

Results of Operations for Period Ending April 30, 2012

We have not generated any revenue during the period from our inception on July 30, 2009 to April 30, 2012, the date of our most recently completed fiscal year. We do not expect to earn any revenues until we are able to complete a prototype of our dog waste retrieval device and successfully manufacture the product.

We incurred operating expenses in the amount of $5,201 during the fiscal year ended April 30, 2012, which consisted of professional fees of $4,700 and general and administrative costs of $501.

Results of Operations for Period Ending April 30, 2012

We incurred operating expenses in the amount of $4,000 during the fiscal year ended April 30, 2011, which consisted of professional fees of $66 and general and administrative costs of $3,934.

We have not attained profitable operations and are dependent upon obtaining financing to complete our proposed business plan. For these reasons, our auditors believe that there is substantial doubt that we will be able to continue as a going concern.

- 18 -

Changes In And Disagreements With Accountants

We have had no changes in or disagreements with our accountants.

Available Information

We have filed a registration statement on form S-1 under the Securities Act of 1933 with the Securities and Exchange Commission with respect to the shares of our common stock offered through this prospectus. This prospectus is filed as a part of that registration statement, but does not contain all of the information contained in the registration statement and exhibits. Statements made in the registration statement are summaries of the material terms of the referenced contracts, agreements or documents of the company. We refer you to our registration statement and each exhibit attached to it for a more detailed description of matters involving the company, and the statements we have made in this prospectus are qualified in their entirety by reference to these additional materials. You may inspect the registration statement, exhibits and schedules filed with the Securities and Exchange Commission at the Commission’s principal office in Washington, D.C. Copies of all or any part of the registration statement may be obtained from the Public Reference Section of the Securities and Exchange Commission, 100 F Street NE, Washington, D.C. 20549. Please call the Commission at 1-800-SEC-0330 for further information on the operation of the public reference rooms.

The Securities and Exchange Commission also maintains a web site at http://www.sec.gov that contains reports, proxy statements and information regarding registrants that file electronically with the Commission. Our registration statement and the referenced exhibits can also be found on this site.

Directors, Executive Officers, Promoters And Control Persons

Our executive officer and director and his age as of the date of this prospectus is as follows:

Directors: Name of Director	Age
Rami Tabet	25

Executive Officers:

Name of Officer	Age	Office
Rami Tabet	25	President and Chief Executive Officer
		Secretary and Treasurer

Biographical Information

Set forth below is a brief description of the background and business experience of each of our executive officers and directors for the past five years.

Rami Tabet

Mr. Tabet has acted as our sole director and officer since January 31, 2012. He has attended College Saint-Joseph Beirut, Hostos College New York, and the American University of Beirut. Mr. Tabet also holds a Master of Business Administration from the Lebanese-Canadian University of Beirut. From January 2011 to December 2012, Mr. Tabet acted as assistant manager with Omnipharma Sal, an importer and distributor of pharmaceutical products that is based in Beirut, Lebanon. Since January 2012, he has been employed as an independent business consultant that specializes in raising mezzanine financing for his clients. Mr. Tabet intends to devote approximately 25% of his business time to our affairs.

- 19 -

Term of Office

Our directors are appointed for a one-year term to hold office until the next annual general meeting of our shareholders or until removed from office in accordance with our bylaws. Our officers are appointed by our board of directors and hold office until removed by the board.

Significant Employees

We have no significant employees other than our sole officer and director.

Executive Compensation

Summary Compensation Table

The table below summarizes all compensation awarded to, earned by, or paid to our executive officers by any person for all services rendered in all capacities to us for the fiscal period from our incorporation on July 30, 2009 to April 30, 2012 (our fiscal year end) and subsequent thereto to the date of this prospectus.

SUMMARY COMPENSATION TABLE

Change in

Pension

Value and

Non-Equity

Nonqualified

Name

Incentive

Deferred

All

and

Stock

Option

Plan

Compensation

Other

Principal

Salary

Bonus

Awards

Compensation

Earnings

Compensation

Total

Position

Year

($)

Rami Tabet
President and CEO

2012
2011
2010

None
None
None

None

Jeff Holt

Secretary and Treasurer

2012
2011
2010

None
None
None

None

Stock Oon Grants

Stock Option Grants

We have not granted any stock options to the executive officers since our inception.

Consulting Agreements

We do not have any employment or consulting agreement with Rami Tabet. We do not pay him any amount for acting as a director.

Security Ownership Of Certain Beneficial Owners And Management

The following table provides the names and addresses of each person known to us to own more than 5% of our outstanding common stock as of the date of this prospectus, and by the officers and directors, individually and as a group as at September 10, 2012. Except as otherwise indicated, all shares are owned directly.

Title of	Name and address	Amount of		Percent
Class	of beneficial owner	beneficial ownership		of class
Common	Rami Tabet		2,000,000		57.14	%
Stock	President, Chief
	Executive Officer,
	and Director
	Mohammad El-Hout Street 305 4 ^th Floor, Fouad Darwish Building Beirut, Lebanon

Common	All Officers and Directors		2,000,000		57.14	%
Stock	as a group that consists of		shares
	one person

- 20 -

The percent of class is based on 3,500,000 shares of common stock issued and outstanding as of the date of this prospectus.

Certain Relationships And Related Transactions

None of the following parties has, since our date of incorporation, had any material interest, direct or indirect, in any transaction with us or in any presently proposed transaction that has or will materially affect us:

* Any of our directors or officers;
* Any person proposed as a nominee for election as a director;
* Any person who beneficially owns, directly or indirectly, shares carrying more than 5% of the voting rights attached to our outstanding shares of common stock;
* Our sole promoter, Rami Tabet;
* Any relative or spouse of any of the foregoing persons who has the same house as such person;
* Immediate family members of directors, director nominees, executive officers and owners of 5% or more of our common stock.

Disclosure Of Commission Position Of Indemnification For
Securities Act Liabilities

Our directors and officers are indemnified as provided by the Nevada Revised Statutes and our Bylaws. We have been advised that in the opinion of the Securities and Exchange Commission indemnification for liabilities arising under the Securities Act is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities is asserted by one of our directors, officers, or controlling persons in connection with the securities being registered, we will, unless in the opinion of our legal counsel the matter has been settled by controlling precedent, submit the question of whether such indemnification is against public policy to court of appropriate jurisdiction. We will then be governed by the court’s decision.

Until 90 days from the date of this prospectus, all dealers that effect transactions in these securities whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealer’s obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.

- 21 -

Part II

Information Not Required In The Prospectus

Other Expenses Of Issuance And Distribution

The estimated costs of this offering are as follows:

Securities and Exchange Commission registration fee	$	1.72
Transfer Agent Fees	$	1,000.00
Accounting fees and expenses	$	5,000.00
Legal fees and expenses	$	1,500.00
Edgar filing fees	$	1,500.00

Total	$	9,001.72

All amounts are estimates other than the Commission’s registration fee.

We are paying all expenses of the offering listed above. No portion of these expenses will be borne by the selling shareholders. The selling shareholders, however, will pay any other expenses incurred in selling their common stock, including any brokerage commissions or costs of sale.

Indemnification Of Directors And Officers

Our officers and directors are indemnified as provided by the Nevada Revised Statutes and our bylaws.

Under the NRS, director immunity from liability to a company or its shareholders for monetary liabilities applies automatically unless it is specifically limited by a company’s articles of incorporation that is not the case with our articles of incorporation. Excepted from that immunity are:

	(1)	a willful failure to deal fairly with the company or its shareholders in connection with a matter in which the director has a material conflict of interest;

	(2)	a violation of criminal law (unless the director had reasonable cause to believe that his or her conduct was lawful or no reasonable cause to believe that his or her conduct was unlawful);

	(3)	a transaction from which the director derived an improper personal profit; and

	(4)	willful misconduct.

Our bylaws provide that we will indemnify our directors and officers to the fullest extent not prohibited by Nevada law; provided, however, that we may modify the extent of such indemnification by individual contracts with our directors and officers; and, provided, further, that we shall not be required to indemnify any director or officer in connection with any proceeding (or part thereof) initiated by such person unless:

	(1)	such indemnification is expressly required to be made by law;

	(2)	the proceeding was authorized by our Board of Directors;

	(3)	such indemnification is provided by us, in our sole discretion, pursuant to the powers vested us under Nevada law; or

	(4)	such indemnification is required to be made pursuant to the bylaws.

Our bylaws provide that we will advance all expenses incurred to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was our director or officer, or is or was serving at our request as a director or executive officer of another company, partnership, joint venture, trust or other enterprise, prior to the final disposition of the proceeding, promptly following request. This advanced of expenses is to be made upon receipt of an undertaking by or on behalf of such person to repay said amounts should it be ultimately determined that the person was not entitled to be indemnified under our bylaws or otherwise.

- 22 -

Our bylaws also provide that no advance shall be made by us to any officer in any action, suit or proceeding, whether civil, criminal, administrative or investigative, if a determination is reasonably and promptly made: (a) by the board of directors by a majority vote of a quorum consisting of directors who were not parties to the proceeding; or (b) if such quorum is not obtainable, or, even if obtainable, a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, that the facts known to the decision- making party at the time such determination is made demonstrate clearly and convincingly that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to our best interests.

Recent Sales Of Unregistered Securities

We issued 2,000,000 shares of our common stock to Sleiman Younes, our former director and officer, on December 29, 2009. He acquired these 2,000,000 shares at a price of $0.001 per share for total proceeds to us of $2,000.00. These shares were issued pursuant to Regulation S of the Securities Act of 1933 (the “Securities Act”). On January 31, 2012, Sleiman Younes sold his 2,000,000 shares of common stock to our current director and officer, Rami Tabet. These shares are considered restricted securities under the Securities Act.

We completed an offering of 1,500,000 shares of our common stock at a price of $0.01 per share to the following 30 purchasers on September 24, 2010:

Name of Subscriber	Number of Shares
Walid Rizk		50,000
Nirmin Awad		50,000
Tony Zahr		50,000
Wissam Hajdar		50,000
Yasmine Bazzi		50,000
Yehia Rahme		50,000
Hadi Youssef Moussa		50,000
Mohamad Hajj		50,000
Youssef Ali Mansour		50,000
Zakiah Riz		50,000
Zeina Riz		50,000
Mohamad Ali Sayegh		50,000
Najwa Sayegh		50,000
Taroub Sayegh		50,000
Jamal Sayegh		50,000
Raeef Sayegh		50,000
Tania Ahmad Assi		50,000
Issam Ahmad Assi		50,000
Ali Hussein Riz		50,000
Yasmeen Gharissa		50,000
Ali Zaateri		50,000
Wissam Gharissa		50,000
Ali Gharissa		50,000
Hussein Youssef Mansour		50,000
Hassan Sayegh		50,000
Moustapha Ghabriss		50,000
Rima Hamdan		50,000
Soha Hamdan		50,000
Bultu Wakjra		50,000
Tigist Biresa		50,000

The total amount received from this offering was $15,000. We completed this offering pursuant to Regulation S of the Securities Act.

Regulation S Compliance

Each offer or sale was made in an offshore transaction;

- 23 -

Neither we, a distributor, any respective affiliates nor any person on behalf of any of the foregoing made any directed selling efforts in the United States;

Offering restrictions were, and are, implemented;

No offer or sale was made to a U.S. person or for the account or benefit of a U.S. person;

Each purchaser of the securities certifies that it was not a U.S. person and was not acquiring the securities for the account or benefit of any U.S. person;

Each purchaser of the securities agreed to resell such securities only in accordance with the provisions of Regulation S, pursuant to registration under the Act, or pursuant to an available exemption from registration; and agreed not to engage in hedging transactions with regard to such securities unless in compliance with the Act;

The securities contain a legend to the effect that transfer is prohibited except in accordance with the provisions of Regulation S, pursuant to registration under the Act, or pursuant to an available exemption from registration; and that hedging transactions involving those securities may not be conducted unless in compliance with the Act; and

We are required, either by contract or a provision in its bylaws, articles, charter or comparable document, to refuse to register any transfer of the securities not made in accordance with the provisions of Regulation S pursuant to registration under the Act, or pursuant to an available exemption from registration; provided, however, that if any law of any Canadian province prevents us from refusing to register securities transfers, other reasonable procedures, such as a legend described in paragraph (b)(3)(iii)(B)(3) of Regulation S have been implemented to prevent any transfer of the securities not made in accordance with the provisions of Regulation S.

Exhibits

Exhibit Number		Description

3.1		Articles of Incorporation
3.2		Bylaws
5.1		Legal opinion of Fox Law Offices, P.A.
23.1		Consent of George Stewart, C.P.A.

The undersigned registrant hereby undertakes:

To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(a)

To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(b)

To reflect in the prospectus any facts or events arising after the effective date of this registration statement, or most recent post-effective amendment, which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement; Notwithstanding the forgoing, any increase or decrease in Volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the commission pursuant to Rule 424(b)if, in the aggregate, the changes in the volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.

(c)

To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in the registration statement.

That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

- 24 -

To remove from registration by means of a post-effective amendment any of the securities being registered hereby which remain unsold at the termination of the offering.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to officers, directors, and controlling persons pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities is asserted our director, officer, or other controlling person in connection with the securities registered, we will, unless in the opinion of our legal counsel the matter has been settled by controlling precedent, submit the question of whether such indemnification is against public policy to a court of appropriate jurisdiction. We will then be governed by the final adjudication of such issue.

Each prospectus filed pursuant to Rule 424(b) as part of a Registration statement relating to an offering, other than registration statements relying on Rule 430(B) or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided; however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by referenced into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.

In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the successful defense of any action, suit or proceeding, is asserted by one of our directors, officers, or controlling person sin connection with the securities being registered, we will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification is against public policy as expressed in the Securities Act, and we will be governed by the final adjudication of such issue.

- 25 -

Signatures

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Beirut, Lebanon, on September 10, 2012.

	Wishbone Pet Products Inc.

	By:	/s/ Rami Tabet
		Rami Tabet
		President, Chief Executive Officer, and Director

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates stated.

SIGNATURE	CAPACITY IN WHICH SIGNED	DATE

/s/ Rami Tabet	President, Chief Executive	September 10, 2012
Rami Tabet	Officer, principal financial officer, principal accounting officer, secretary, treasurer and director

- 26 -

by - laws

Wishbone Pet Products Inc .

a Nevada corporation

article 1

Offices

Section 1 . The registered office of this corporation is in the city of Reno, Nevada.

Section 2. The corporation may also have offices at other places both within and without the State of Nevada as the directors may determine or the business of the corporation may require.

article 2

Meetings of Stockholders

Section 1. Annual meetings of the stockholders must be held at the registered office of the corporation or at any other place within or without the State of Nevada as the directors may decide. Special meetings of the stockholders may be held at the time and place within or without the State of Nevada as is stated in the notice of the meeting, or in a duly executed waiver of notice.

Section 2. Annual meetings of the stockholders must be held on the anniversary date of incorporation each year if it is not a legal holiday and, and if it is a legal holiday, then on the next secular day following, or at another time as the directors may decide, at which the stockholders will elect the directors and transact any other business that is properly before the meeting.

Section 3. The president or the secretary may, by resolution of the directors or on the written request of the stockholders owning a majority of the issued and outstanding shares and entitled to vote, call special meetings of the stockholders for any purpose unless otherwise prescribed by statute or by the articles of incorporation. A request must state the purpose of the proposed meeting.

Section 4. Notices of meetings must be written and signed by the president or vice-president or the secretary or an assistant secretary or by any other person designated by the directors. The notice must state the purpose for which the meeting is called and the time and the place, which may be within or without the State, where it is to be held. A copy of the notice must be either delivered personally or mailed, postage prepaid, to each stockholder of record entitled to vote at the meeting not less than 10 and not more than 60 days before the meeting. If it is mailed, it must be directed to a stockholder at the address that appears upon the records of the corporation and is deemed to be delivered to the stockholder when it is deposited into the mail. If a stockholder is a corporation, association or partnership, the notice is deemed to have been delivered to the stockholder it is delivered personally to an officer of the corporation or association, or to any member of a partnership. A transferee is not entitled to notice of a meeting if the stock is transferred after the notice is delivered and before the meeting is held.

Section 5. Business transactions at any special meeting of stockholders is limited to the purpose stated in the notice.

Section 6. The holders of one-third of the stock issued and outstanding and entitled to vote and present in person or represented by proxy, constitutes a quorum at all meetings of the stockholders for the transaction of business except as otherwise provided by statute or by the articles of incorporation. If a quorum is not present or represented at any meeting of the stockholders, the stockholders who are entitled to vote and present in person or represented by proxy may adjourn the meeting from time to time, without notice other than announcements at the meeting. At such adjourned meeting, the quorum shall be equal to the number of issued and outstanding shares of the corporation present in person or by proxy and any business may be transacted at the adjourned meeting as originally notified. The shareholders present at a duly organized meeting may continue to transact business until adjournment of the meeting, notwithstanding the withdrawal of shareholders from the meeting so that less than a quorum remains.

Wishbone Pet Products Inc.

BY-LAWS

2 of 8

Section 7. When a quorum is present or represented at any meeting, the vote of the holders of 10% of the stock having voting power present in person or represented by proxy is sufficient to elect directors or to decide any question brought before the meeting unless the statute or the articles of incorporation specify that the question requires that a different percentage is required to decide the question.

Section 8. Each stockholder of record of the corporation is entitled at each meeting of the stockholders to one vote for each share standing in his name on the books of the corporation. Any stockholder may demand that the vote for directors and any question before the meeting be by ballot.

Section 9. At any meeting of the stockholders any stockholder may be represented and vote by a proxy or proxies appointed by in writing. If the written proxy designates two or more persons to act as proxies, a majority of the designated persons present at the meeting, or one if only one is present, has the powers conferred by the written instruction. No proxy or power of attorney to vote may be voted at a meeting of the stockholders unless it has been filed with the secretary of the meeting when required by the inspectors of election. All questions regarding the qualifications of voters, the validity of proxies, and the acceptance or rejection of votes must be decided by the inspectors of election who are appointed by the directors, or if not appointed, then by the officer presiding at the meeting.

Section 10 . Any action that may be taken by the vote of the stockholders at a meeting may be taken without meeting if it is authorized by the written consent of stockholders holding at least a majority of the voting power, unless the provisions of the statute or the articles of incorporation require a greater proportion of voting power to authorize the action, in which case the greater proportion of written consents is required.

ARTICLE 3

Directors

Section 1. The directors must manage business of the corporation and they may exercise all the powers of the corporation and do any lawful thing unless the statute or the articles of incorporation or these bylaws specify that the stockholders have the power to do the thing.

Section 2 . The number of directors that constitutes the whole board may not be less than one or more than eight. The directors at any time may increase or decrease the number of directors to not less than one and not more than eight. The stockholders will elect the directors at the annual meeting of the stockholders and, except as provided in section 3 of this article, each director’s term of office will be one year or until a successor is elected and qualified. Directors may be re-elected for successive annual terms. Directors need not be stockholders.

Section 3. A majority of the remaining directors, even if they are less than a quorum, or a sole remaining director may fill any vacancies in the board of directors, including those caused by an increase in the number of directors, and each director so elected holds office until a successor is elected at the annual or a special meeting of the stockholders. The holders of a two-thirds of the outstanding shares of stock entitled to vote may at any time peremptorily terminate the term of office of all or any of the directors by voting at a meeting called for the purpose or by a written statement filed with the secretary or, if the secretary is absent, with any other officer. The removal is effective immediately even if successors are not elected simultaneously, and the resulting vacancies on the board of directors may be filled only from the stockholders.

A vacancy on the board of directors is deemed to exist if a director dies, resigns or is removed, or if the authorized number of directors is increased, or if the stockholders fail to elect the number of directors to be elected t any annual or special meeting of stockholders at which any director is to be elected.

Wishbone Pet Products Inc.

BY-LAWS

3 of 8

The stockholders may elect a director at any time to fill any vacancy not filled by the directors. If the directors accept the resignation of a director tendered to take effect at a future time, the board or the stockholders may elect a successor to take office when the resignation becomes effective.

Neither the directors nor the stockholders can reduce the authorized number of directors to cause the removal of any director before the expiration of his term of office.

ARTICLE 4

Meeting of the Board of Directors

Section 1. Regular meetings of the board of directors must be held at any place within or without the State that is designated by a resolution of the board or the written consent of all members of the board. In the absence of a designation, regular meetings must be held at the registered office.

Section 2. The first meeting of each newly elected board of directors should be held immediately following the adjournment of the meeting of stockholders and at the place of the meeting. A notice of the meeting is not necessary in order legally to constitute the meeting if a quorum is present. If the meeting is not held then, it may be held at the time and place that is specified in a notice given as these bylaws provide for special meetings of the directors.

Section 3. Regular meetings of the board of directors may be held without call or notice at the time and at the place that is fixed by the directors.

Section 4. Special meetings of the directors may be called by the chairman or the president or by the vice-president or by any two directors.

Written notice of the time and place of special meetings must be delivered personally to each director, or sent to each director by mail or by other form of written communication, charges prepaid, addressed to the director at the address as it is shown upon the records or, if not readily ascertainable, at the place in which the meetings of the directors are regularly held. If the notice is mailed or telegraphed, it will be deposited in the postal service or delivered to the telegraph company at least 48 hours before the meeting is scheduled to start. If the notice is delivered or faxed, it must be delivered or faxed at least 24 hours before the meeting is scheduled to start. Delivery as described in this article is be legal and sufficient notice to the director.

Section 5. Notice of the time and place for convening an adjourned meeting need not be given to the absent directors if the time and place has been fixed at the meeting adjourned.

Section 6. The transaction of business at any meeting of the directors, however called and noticed or wherever held, is as valid as though transacted at a meeting duly held after regular call and notice if a quorum is present and if, either before or after the meeting, each of the directors not present signs a written waiver of notice or a consent to meeting’s being held, or written approvals are filed with the corporate records or made a part of the minutes of the meeting.

Section 7. A majority of the authorized number of directors constitutes a quorum for the transaction of business, except to adjourn as described in these bylaws. Every decision made by a majority of the directors present at a meeting duly held at which a quorum is present is deemed to be the decision of the board of directors unless a greater number is required by law or by the articles of incorporation. Any action of a majority, although not at a regularly called meeting, and the record of it if the other directors have consented in writing, is as valid and effective in all respects as if it were passed by the board in regular meeting.

Section 8. A quorum of the directors may adjourn any directors’ meeting to meet again at a stated day and hour; but, in the absence of a quorum, a majority of the directors present at any directors’ meeting, either regular or special, may adjourn the meeting to the next regular meeting of the board.

Wishbone Pet Products Inc.

BY-LAWS

4 of 8

Section 9. Any action required or permitted to be taken by the vote of the directors at a meeting may be taken without a meeting if, before or after the action, it is authorized by the written consent of all the directors.

ARTICLE 5

Committees of Directors

Section 1. The directors may, by resolution adopted by all of them, designate one or more committees of the directors, each to consist of two or more of the directors. A committee may exercise the power of the whole board in the management of the business of the corporation and may authorize the fixing of the seal of the corporation to any document that requires it. The directors may name the committee. The members of the committee present at any meeting and not disqualified from voting may, whether or not they constitute a quorum, unanimously appoint another member of the board to act at the meeting in the place of any absent or disqualified member. The consent of a majority of the members or alternate members at any meeting of a committee that has a quorum is required to approve any act of the committee.

Section 2. The committee must keep regular minutes of their proceedings and report them to the whole board.

Section 3. Any action that must or may be taken at meetings of the directors or any committee of them may be taken without a meeting if the directors on the board or committee consent unanimously in writing and the written consent is filed with the minutes of the proceedings of the board or committee.

ARTICLE 6

Compensation of Directors

Section 1. The directors may be paid their expenses for attending each meeting of the directors and may be paid a fixed sum for attendance at each meeting of the directors or a stated salary as director. No payment precludes any director from serving the corporation in any other capacity and being compensated for the service. Members of special or standing committees may be allowed like reimbursement and compensation for attending committee meetings.

ARTICLE 7

Notices

Section 1. Notices to directors and stockholders must be written and delivered personally or mailed to the directors or stockholders at their addresses as they appear on the books of the corporation. Notices to directors may also be given by fax and by telegram. Notice by mail, fax or telegram is deemed to be given when the notice is mailed, faxed or telegraphed.

Section 2. Whenever all parties entitled to vote at any meeting, whether of directors or stockholders, consent, either by writing on the records of the meeting or filed with the secretary, or by their presence at the meeting or oral consent entered on the minutes, or by taking part in the deliberations at the meeting without objection, the doings of the meeting are as valid as if they were done at a meeting regularly called and noticed, and at the meeting any business may be transacted that is not excepted from the written consent if no objection for want of notice is made at the time and, if any meeting is irregular for want of notice or consent and a quorum was present at the meeting, the proceedings of the meeting may be ratified and approved and rendered valid and the irregularity or defect is waived if all parties having the right to vote at the meeting consent in writing. The consent or approval of stockholders may be by proxy or attorney, but all the proxies and powers of attorney must be in writing.

Section 3. Whenever any notice is required to be given under the provisions of the statute, the articles of incorporation or these bylaws, a written waiver signed by the persons entitled to the notice, whether before or after the time stated, is deemed to be equivalent.

Wishbone Pet Products Inc.

BY-LAWS

5 of 8

ARTICLE 8

Officers

Section 1. The directors will choose the officers of the corporation. The offices to be filled are president, secretary and treasurer. A person may hold two or more offices.

Section 2. The directors at their first meeting after each annual meeting of stockholders will choose a chairman of the board of directors from among themselves, and will choose a president, a secretary and a treasurer, none of whom must be directors.

Section 3. The directors may appoint a vice-chairman of the board, vice-presidents and one or more assistant secretaries and assistant treasurers and other officers and agents as it deems necessary to hold their offices for the terms and exercise the powers and perform the duties determined by the directors.

Section 4. The directors will fix the salaries and compensation of all officers of the corporation.

Section 5. The officers of the corporation hold their offices at the pleasure of the directors. Any officer elected or appointed by the directors may be removed any time by the directors. The directors will fill any vacancy occurring in any office of the corporation by the death, resignation, removal or otherwise.

Section 6. The chairman of the board will preside at meetings of the stockholders and of the directors and will see that the orders and resolutions of the directors are carried into effect.

Section 7. The vice-chairman will, if the chairman is absent or disabled, perform the duties and exercise the powers of the chairman of the board and will perform other duties as the directors may prescribe.

Section 8. The president is the chief executive officer of the corporation and will manage the business of the corporation. He will execute on behalf of the corporation all instruments requiring execution unless the signing and execution of them is expressly designated by directors to some other officer or agent of the corporation.

Section 9. The vice-presidents will act under the direction of the president and, if the president is absent or disabled, will perform the duties and exercise the powers of the president. They will perform the other duties and have the other powers prescribed by the president or directors. The directors may designate one or more executive vice-presidents and may specify the order of seniority of the vice-presidents. The duties and powers of the president descend to the vice-presidents in the specified order of seniority.

Section 10. The secretary will act under the direction of the president; will attend and record the proceedings at all meetings of the directors and the stockholders and at the standing committees when required; will give or cause to be given notice of all meetings of the stockholders and special meetings of the directors; and will perform other duties that are prescribed by the president or the directors.

Section 11. The assistant secretaries will act under the direction of the president in the order of their seniority unless the president or the directors decide otherwise, and they will perform the duties and exercise the powers of the secretary if the secretary is absent or disabled. They will perform other duties and have the other powers that are prescribed by the president and the directors.

Section 12. The treasurer will (I) act under the direction of the president with custody of the corporate funds and securities; (ii) keep full and accurate accounts of receipts and disbursements in books belonging to the corporation; (iii) deposit all money and other valuable effects in the name and to the credit of the corporation in the depositories that are designated by the directors; (iv) disburse the funds of the corporation as ordered by the president or the directors, taking proper vouchers for the disbursements; and (v) render to the president and the directors, at their regular meetings or when the directors require, an account of all the transactions undertaken by the treasurer and of the financial condition of the corporation.

Wishbone Pet Products Inc.

BY-LAWS

6 of 8

If the directors require, the treasurer will give the corporation a bond in the sum and with the surety that is satisfactory to the directors for the faithful performance of the duties of his office and for the restoration to the corporation, if he dies, resigns, retires or is removed from office, of all books, papers, vouchers, money and other property of whatever kind in his possession or under his control belonging to the corporation.

Section 13 . The assistant treasurers in order of their seniority, or as determined by the president or the directors, will perform the duties and exercise the powers of the treasurer if the treasurer is absent or disabled. They will perform the other duties and have the other powers that are prescribed by the president or the directors.

ARTICLE 9

Certificates of Stock

Section 1. Every stockholder is entitled to have a certificate signed by the president or a vice-president and the treasurer or an assistant treasurer, or the secretary or an assistant secretary of the corporation, that certifies the number of shares owned by him in the corporation. If the corporation is authorized to issue more than one class of stock or more that one series of any class, the designations, preferences and relative, participating, optional or other special rights of the various classes of stock or series and the qualifications, limitation or restrictions of the rights, must be described in full or summarized on the face or back of the certificate that the corporation issues to represent the stock.

Section 2. If a certificate is signed (a) by a transfer agent other than the corporation or its employees or (b) by a registrar other than the corporation or its employees, the signatures of the officers of the corporation may be facsimiles. If any officer who has signed or whose facsimile signatures has been placed upon a certificate ceases to be the officer before the certificate is issued, the certificate may be issued with the same effect as though the person had not ceased to be the officer. The seal of the corporation or a facsimile of it may, but need not be, affixed to certificates of stock.

Section 3. The directors may direct that a new certificate be issued in place of any certificate issued by the corporation that is alleged to have been lost or destroyed if the person claiming the loss or destruction of the certificate makes an affidavit of that fact. When they authorize the issuance of a new certificate, the directors may, in their discretion and as a condition precedent to the issuance of the new certificate, require that the owner of the lost or destroyed certificate or his legal representative advertise the loss as it requires or give the corporation a bond in the sum as it may direct as indemnity against any claim that may be made against the corporation with respect to the certificate alleged to have been lost or destroyed.

Section 4. When a certificate for shares, duly endorsed or accompanied by proper evidence of succession, assignment or authority to transfer, is surrendered to the corporation or the corporation’s transfer agent, the corporation must, if it is satisfied that it complies with the laws and regulations applicable to the corporation regarding the transfer and ownership of shares, issue a new certificate to the person entitled to it and will cancel the old certificate and record the transaction upon its books, subject to the provisions of the corporation’s Articles and these By-laws and to restrictions on transfer, if any, contained in these By-laws. If the corporation is not a reporting corporation with its shares listed for trading then no shares can be transferred without the consent of the directors expressed by a resolution of the board of directors. The board of directors will not be required to give any reason for refusing to consent to any such proposed transfer.

Section 5. The directors may fix in advance a date not more than 60 days and not less than 10 days before the date of any meeting of stockholders, or the date of the payment of any dividend, or the date of the allotment of rights, or the date when any change or conversion or exchange of capital stock is effective, or a date in connection with obtaining the consent of stockholders for any purpose, as a record date for the determination of the stockholders entitled to notice of and to vote at any meeting or adjournment, or entitled to be paid any dividend, or to consent to any matter for which stockholders’ consent is required, and, in any case, only the stockholders who are stockholders of record on the date so fixed are entitled to notice of and to vote as the meeting or any adjournment, or to be paid a dividend, or to be allotted rights, or to exercise the rights, or to consent, as the case may be, notwithstanding any transfer of any stock on the books of the corporation after the record date is fixed.

Wishbone Pet Products Inc.

BY-LAWS

7 of 8

Section 6. The corporation is entitled to recognize the person registered on its books as the owner of the share as the exclusive owner for all purposes including voting and dividends, and the corporation is not bound to recognize any other person’s equitable or other claims to or interest in the shares, whether it has express or other notice of a claim, except as otherwise provided by the laws of Nevada.

ARTICLE 10

General Provisions

Section 1 . The directors may declare dividends upon the capital stock of the corporation, subject to the provisions of the articles of incorporation, if any, at any regular or special meeting, pursuant to law. Dividends may be paid in cash, in property or in shares of the capital stock, subject to the provisions of the articles of incorporation.

Section 2. Before it pays any dividend, the corporation may set aside out of any funds of the corporation available for dividends the sum that the directors, in their absolute discretion, think proper as a reserve to meet contingencies, or for equalizing dividends, or for repairing and maintaining any property of the corporation, or for the another purpose that the directors determine are in the interests of the corporation, and the directors may modify or abolish any the reserve in the manner that it was created.

Section 3. All checks or demands for money and notes of the corporation must be signed by the officers or other persons that are designated by the directors.

Section 4 . The directors will fix the fiscal year of the corporation.

Section 5. The directors may resolve to adopt a corporate seal for the corporation. The name of the corporation must be inscribed on the seal with the words “Corporate Seal” and “Nevada”. The seal may be used by causing it or a facsimile of it to be impressed or affixed or in any manner reproduced.

ARTICLE 11

Acquisition of Controlling Interested

Section 1. The provisions of NRS 76.378 to 78.3793 and any amendments to the Private Corporations Act (Nevada) that pertain to the acquisition of a controlling interest do not apply to the corporation.

ARTICLE 12

Indemnification

Section 1. Every person who was or is a party or is a threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, because he or a person whom he legally represents is or was a director or officer of the corporation or is or was serving at the request of the corporation or for its benefit as a director or officer of another corporation, or as its representative in a partnership, joint venture, trust or other enterprise, is indemnified and held harmless to the fullest legally permissible under the General Corporation Law of the State of Nevada from time to time against all expenses, liability and loss (including attorney’s fees, judgments, fines and amounts paid or to be paid in settlements) reasonably incurred or suffered by him in connection with his acting. The expenses of officers and directors incurred in defending a civil or criminal action, suit or proceeding must be paid by the corporation as they are incurred and in advance of the final disposition of the action, suit or proceeding upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that he is not entitled to be indemnified by the corporation. The right of indemnification is a contract right that may be enforced in any manner desired by the person. The right of indemnification does not extinguish any other right that the directors, officers or representatives may have or later acquire and, without limiting the generality of the statement, they are entitled to their respective rights of indemnification under any bylaw, agreement, vote of stockholders, provision of law or otherwise, as well as their rights under this article.

Wishbone Pet Products Inc.

BY-LAWS

8 of 8

Section 2. The directors may cause the corporation to purchase and maintain insurance on behalf of any person who is or was a director or officer of the corporation, or is or was serving at the request of the corporation as a director or officer of another corporation, or as its representative in a partnership, joint venture, trust or other enterprise against any liability asserted against the person and incurred in any capacity or arising out of the status, whether or not the corporation would have the power to indemnify the person.

Section 3. The directors may adopt other bylaws regarding indemnification and may amend the bylaws to provide at all times the fullest indemnification permitted by the General Corporation Law of the State of Nevada.

ARTICLE 13

Amendments

Section 1. The bylaws may be amended by the majority vote of all the record holders of stock issued and outstanding and entitled to vote at any annual or special meeting of the stockholders, if the notice of the meeting contains a notice of the intention to amend.

Section 2. The directors by a majority vote of the whole board of directors at any meeting may amend these bylaws, including bylaws adopted by the stockholders, but the stockholders may specify particulars of the bylaws that cannot be amended by the board of directors.

Approved and adopted on July 30, 2009

CERTIFICATE OF THE SECRETARY

I, Sleiman Younes, certify that I am the corporate secretary of Wishbone Pet Products Inc. and that the foregoing bylaws consisting of 8 pages constitute the code of bylaws of this corporation as duly adopted at a regular meeting of the directors of the corporation held on July 30, 2009.

July 30, 2009

/s/ Sleiman Younes
Sleiman Younes- Corporate Secretary

Wishbone Pet Products Inc.

GEORGE STEWART, CPA

316 17 ^TH AVENUE SOUTH

SEATTLE, WASHINGTON 98144

(206) 328-8554 FAX (206) 328-0383

To Whom It May Concern:

The firm of George Stewart, Certified Public Accountant consents to the inclusion of our report on the Financial Statements of Wishbone Pet Products Inc. as of April 30, 2012, 2011 and 2010, in any filings that are necessary now or in the near future with the U. S. Securities and Exchange Commission.

We also consent to the reference to us under the heading “Experts” in this registration statement.

Very Truly Yours,

/S/ George Stewart

George Stewart, CPA

September 10, 2012